Global Cell Lysis Market Is Anticipated To Witness Significant Growth Due To Rising Investments And Growing Demand For Efficient Tumor Tissue Dissociation Equipment

Cell Lysis Market

Overview:

Cell lysis is the process of breaking down a cell by disrupting its membrane and releasing its intracellular components. This method can be used to lyse cells of different types including eukaryotic and prokaryotic cells. Most common cell lysis methods involve mechanical disruption of the membrane using shear or frictional forces and compressive stresses. This type of lysis can be performed using rotor/stator shear homogenizer, solid pressure shear, impingement jet and colloid mills.

Sonication is not widely used for single-cell lysis, as it can be used to lyse cells within 3 s after first treating them with a detergent such as digitonin. This technique requires heating or sonication and may damage proteins or cause excessive diffusion of the cell content. Electrical lysis is not widely used for single-cell lysing. It can be used to lyse single adherent cells or settled suspension cells using electrical energy or currents. This technique can be used to lyse cells at low concentrations with a single pass through an electrode.

Market Dynamics:

Growing adoption of inorganic strategies are estimated to augment growth of the global Cell Lysis Market over the forecast period. For instance, IGM Biosciences, Inc., and Sanofi declared signing an exclusive worldwide collaboration agreement in March 2022. For creating, developing manufacturing and commercializing IgM antibody. Moreover, lack of healthcare budgeting in developing countries, and increasing ethical issues of modifying genes are anticipated to restrain growth of the global cell lysis for market over the forecast period.

Impact of COVID-19:

COVID-19 had a positive impact on the growth of the market. As there was an increase in number of R&D activities for developing COVID-19 vaccines and drugs. This resulted in rising demand for use of bioprocessing techniques, such cell lysis and disruption. Several pharmaceutical companies and research institutes were focusing on research activities for battling COVID-19.

This became even more important as the number of COVID-19 patients were increasing on a daily basis globally. This outbreak was declared as a public health emergency by the World Health Organization in 2020. Thus, the global Cell Lysis for Market witness growth during the pandemic.

Key Takeaways:

The global Cell Lysis Market is expected to witness high growth, exhibiting CAGR of 9.35 % over the forecast period, due to increasing acquisitions by key players.

For instance, Henogen S.A., was acquired by Thermo Fisher Scientific, Inc., in January 2021. This acquisition will expand their cell and gene therapies & vaccines.

North America is anticipated to witness significant growth in the global cell lysis for market over the forecast period, owing to growing government initiatives for supporting cancer research in the U.S and Canada.

Major players operating in the global Cell Lysis Market are Qsonica LLC, Thermo Fisher Scientific, Inc., Covaris, Inc., Merck KGaA, BioVision, Inc, F. Hoffmann-La Roche Ltd., Parr Instrument Company, Qiagen NV, Microfluidics International Corp., Becton Dickinson & Company, Claremont BioSolutions, LLC, Danaher Corp., Miltenyi Biotec GmbH, and Bio-Rad Laboratories, Inc.